Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis
- 196 Downloads
Factors responsible for the progression of primary biliary cirrhosis (PBC) are still poorly understood. In the present study, we investigated the associations between the stage of PBC and the immune reaction triggered by oxidative stress; the presence of obesity, steatosis, steatohepatitis; and other toxic, metabolic, or steatogenic factors.
We studied clinical, laboratory, and histological data for 274 untreated patients with serum antimitochondrial antibody (AMA)-positive PBC. Circulating IgG against human serum albumin adducted with malondialdeyde, the major product of lipid peroxidation, was measured in these patients and in a group of 98 sex-, age- and body mass index (BMI)-matched controls.
Steatosis was present in 40.5% of all patients. Steatohepatitis was present in 14.9% of all patients. There was a significant association between the frequencies of steatosis and steatohepatitis and the worsening of PBC. Circulating IgG against lipid peroxidation products was significantly higher in the PBC patients than in the controls. Titers of lipid peroxidation-related antibodies were significantly increased in patients with steatosis and in patients at more advanced stages. Bivariate analysis revealed a significant association between indirect evidence of oxidative stress, steatosis, steatohepatitis, age, BMI, frequency of diabetes, alcohol intake, iron grade after Perl’s stain, and PBC stage. Logistic regression analysis confirmed that the titers of antibodies against lipid peroxidation products (odds ratio 4.5, p < .001, 95% confidence interval 3.9–14.4), the presence of steatosis (odds ratio 4.1, 95% confidence interval 2.5–15.4, p < .001), higher BMI (odds ratio 3.9, p < .021, 95% confidence interval 1.4–9.5), and alcohol intake (males ≥ 30 g/day, females ≥ 20 g/day, odds ratio 4.5, 95% confidence interval 1.3–19.8, p < .029) were independently associated with more advanced stages of the disease.
The immune reactions triggered by oxidative stress, steatosis, obesity, and alcohol intake are independent predictors of PBC stage progression.
KeywordsAutoimmune cholangitis Primary biliary cirrhosis Oxidative stress Lipid peroxidation Steatosis BMI Alcohol Iron Obesity
- 1.Sasaki M, Ikeda H, Nakanuma Y. Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21WAF1/Cip1 in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: an immunohistochemical study. J Autoimmun. 2008;31:73–8.CrossRefPubMedGoogle Scholar
- 4.Leandro G, Mangia A, Hui J, Fabris P, Rubbia-Brandt L, Colloredo G, et al. HCV Meta-Analysis (on) Individual Patients’ Data Study Group. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology. 2006;130:1636–42.CrossRefPubMedGoogle Scholar
- 12.Searle JW, Kerr JFR, Halliday JW, Powell LW. Iron storage disease. In: MacSween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the liver. 3rd ed. Edinburgh: Churchill Livingstone; 1994. p. 257–72.Google Scholar
- 13.Portmann BC, Nakanuma Y. Disease of the bile duct. In: MacSween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the liver. 3rd ed. Edinburgh: Churchill Livingstone; 1994. p. 435–506.Google Scholar
- 17.Karadeniz G, Acikgoz S, Tekin IO, Tascýlar O, Gun BD, Cömert M. Oxidized low-density-lipoprotein accumulation is associated with liver fibrosis in experimental cholestasis. Clinics (Sao Paulo). 2008;63:531–40.Google Scholar
- 40.Ono M, Sekiya C, Ohhira M, Ohhira M, Namiki M, Endo Y, et al. Elevated level of serum Mn-superoxide dismutase in patients with autoimmune cholangitis: possible involvement of free radicals in the pathogenesis in autoimmune cholangitis. J Lab Clin Med. 1999;118:476–83.Google Scholar
- 41.Kadokawa Y, Ohba K, Omagari K, Akazawa S, Hayashida K, Ohnita K, et al. Intracellular balance of oxidative stress and cytoprotective molecules in damaged interlobular bile ducts in autoimmune hepatitis and autoimmune cholangitis: in situ detection of 8-hydroxydeoxyguanosine and glutathione-S-transferase-pi. Hepatol Res. 2007;37:620–7.CrossRefPubMedGoogle Scholar
- 55.Ratziu V, Giral P, Jacqueminet S, Charlotte F, Hartemann-Heurtier A, Serfaty L, LIDO Study Group, et al. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) trial. Gastroenterology. 2008;135:100–10.CrossRefPubMedGoogle Scholar